Clinical pharmacokinetics of clozapine in chronic schizophrenic patients
- 1 January 1988
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 34 (5) , 445-449
- https://doi.org/10.1007/bf01046700
Abstract
The clinical pharmacokinetics of clozapine, an atypical neuroleptic, was evaluated in 10 chronic schizophrenic male patients after intravenous and oral administration. The mean equilibrium-state concentration ratio between blood and plasma was experimentally determined to be 0.87. The average values for blood clearance, hepatic extraction ratio and oral bioavailability were 250 ml/min, 0.2 and 0.27, respectively. Plasma concentration peaked on average at 3 h. The mean volume of distribution at steady-state and the terminal half-life was 1.6 l/kg and 10.3 h, respectively. A large fraction of the dose is most probably metabolized by some extrahepatic presystemic routes. The large inter-individual variability in the bioavailability and clearance is probably the main reason for large variation in the steady-state plasma level in patients receiving the same oral dosage regimen.This publication has 16 references indexed in Scilit:
- Receptor binding of N-(methyl-11C) clozapine in the brain of rhesus monkey studied by positron emission tomography (PET)Psychopharmacology, 1986
- Therapeutic effects of clozapineActa Psychiatrica Scandinavica, 1979
- Clozapine treatment of schizophrenic patients ‐ PLASMA CONCENTRATION AND COAGULATION FACTORSActa Psychiatrica Scandinavica, 1977
- Clozapine-induced agranulocytosis: A situation report up to August 1976European Journal of Clinical Pharmacology, 1977
- Effects of neuroleptics on striatal dopamine synthesized from 14C-tyrosinePharmacology & Therapeutics. Part B: General and Systematic Pharmacology, 1976
- Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazinePsychopharmacology, 1975
- CLOZAPINE AND HALOPERIDOL IN A SINGLE‐BLIND CROSS‐OVER TRIAL: THERAPEUTIC AND BIOCHEMICAL ASPECTS IN THE TREATMENT OF SCHIZOPHRENIAActa Psychiatrica Scandinavica, 1974
- Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic systemJournal of Pharmacy and Pharmacology, 1973
- Effects of clozapine on cerebral catecholaminergic neurone systemsBritish Journal of Pharmacology, 1972
- Ergebnisse eines Doppelblindversuches von HF 1854*(8-Chlor-11-(4-methyl-1-piperazinyl)-5H-dibenzo (b, e) (1,4) diazepin) im Vergleich zu LevomepromazinPharmacopsychiatry, 1971